Can the routine use of fluoroquinolones for community-acquired pneumonia delay the diagnosis of tuberculosis? A salutary case of diagnostic delay in a pilgrim returning from Mecca

L. Sølling Avnon, A. Jotkowitz, A. Smoliakov, D. Flusser, D. Heimer

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Guidelines advocate using fluoroquinolones as first-line treatment for community-acquired pneumonia (CAP). However, the use of fluoroquinolones in patients with undiagnosed tuberculosis may cause a delay in the diagnosis of tuberculosis and may also promote the development of resistance to these drugs if used as monotherapy in undiagnosed tuberculosis. We illustrate the former with the following case report of a patient who developed tuberculosis after a pilgrimage to Mecca.

Original languageEnglish
Pages (from-to)444-446
Number of pages3
JournalEuropean Journal of Internal Medicine
Volume17
Issue number6
DOIs
StatePublished - 1 Oct 2006
Externally publishedYes

Keywords

  • Community-acquired pneumonia
  • Delay in tuberculosis diagnosis
  • Fluoroquinolones
  • Mecca pilgrimage
  • Mycobacterium tuberculosis

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Can the routine use of fluoroquinolones for community-acquired pneumonia delay the diagnosis of tuberculosis? A salutary case of diagnostic delay in a pilgrim returning from Mecca'. Together they form a unique fingerprint.

Cite this